Press Releases
Keyword Search
12.09.20
OpGen Announces Planned Leadership Transition at Next Generation Sequencing and Bioinformatics Subsidiary Ares Genetics
12.01.20
OpGen Group Company Ares Genetics Advances ares-genetics.cloud Platform, Presents Update at Scientific Conferences, Expects Granting of Key Patent
11.24.20
OpGen, Inc. Announces $10 Million Private Placement Priced at the Market
11.12.20
OpGen Group Company Ares Genetics Commercially Launches NGS-based Antibiotic Resistance Testing Service for Native Specimens and Receives Bulk Order from Public Health Agency
11.11.20
OpGen Reports Third Quarter 2020 Financial Results and Provides Business Update
10.29.20
OpGen to Provide Business Update and Financial Results for the Third Quarter 2020
10.28.20
OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators
10.15.20
OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudited Revenue and Cash Position for the Third Quarter 2020
10.13.20
OpGen Issues Formal Response to FDA’s Requests for Additional Information and Expects Near Term FDA Clearance Decision for Acuitas AMR Gene Panel
10.05.20
OpGen Group Company Ares Genetics Wins Austrian Digitization Award for ares-genetics.cloud